The mean incremental improvements in QALE with oral semaglutide 14 mg were 0.09, 0.18 and 0.07 QALYs versus empagliflozin 25 mg, sitagliptin 100 mg and liraglutide 1.8 mg, respectively
Instead of focusing only on surface treatments, the brand integrates internal nutritional support with dermatology-informed formulations
Then scale up to the annual impact so the decision-maker can justify the spend
(PubMed) Lavery AM, Brender JD, Zhao H, et al
10.1038/nature12111 66 HuangW.WangY.TianW.CuiX.TuP.LiJ.et al (2022)
For example, Mounjaro is approved to treat Type 2 diabetes, but it also reduces appetite